๐๐ถ๐ด๐ผ๐ ๐ถ๐ป — ๐ ๐๐น๐ฎ๐๐๐ถ๐ฐ ๐๐ฟ๐๐ด ๐๐ถ๐๐ต ๐ฎ ๐ง๐ถ๐บ๐ฒ๐น๐ฒ๐๐ ๐ ๐ฒ๐ฐ๐ต๐ฎ๐ป๐ถ๐๐บ
๐๐ถ๐ด๐ผ๐ ๐ถ๐ป — ๐ ๐๐น๐ฎ๐๐๐ถ๐ฐ ๐๐ฟ๐๐ด ๐๐ถ๐๐ต ๐ฎ ๐ง๐ถ๐บ๐ฒ๐น๐ฒ๐๐ ๐ ๐ฒ๐ฐ๐ต๐ฎ๐ป๐ถ๐๐บ
Digoxin, one of the oldest cardiac drugs still in use today, continues to play a critical role in the management of heart failure and atrial fibrillation. Despite newer agents, digoxin remains unique because of its dual action — both inotropic and chronotropic.
Let’s dive into its mechanism of action, step by step.
---
๐ฌ ๐ ๐ผ๐น๐ฒ๐ฐ๐๐น๐ฎ๐ฟ ๐ง๐ฎ๐ฟ๐ด๐ฒ๐: ๐ก๐ฎ⁺/๐⁺-๐๐ง๐ฃ๐ฎ๐๐ฒ ๐๐ป๐ต๐ถ๐ฏ๐ถ๐๐ถ๐ผ๐ป
At the core of digoxin’s mechanism lies its inhibition of the Na⁺/K⁺-ATPase pump, located on the cardiac cell membrane.
Normally, this pump extrudes 3 Na⁺ ions out of the cell and brings in 2 K⁺ ions, maintaining the electrochemical gradient.
Digoxin binds to the extracellular domain of this pump, inhibiting its activity.
This causes intracellular Na⁺ concentration to rise.
This simple change triggers a cascade of ionic effects that ultimately increase cardiac contractility.
---
⚙️ ๐ฆ๐๐ฒ๐ฝ-๐ฏ๐-๐ฆ๐๐ฒ๐ฝ ๐ ๐ฒ๐ฐ๐ต๐ฎ๐ป๐ถ๐๐บ
1. Inhibition of Na⁺/K⁺-ATPase
⬇
Leads to an increase in intracellular Na⁺ concentration.
2. Reduced Na⁺/Ca²⁺ Exchange
Normally, Na⁺/Ca²⁺ exchanger (NCX) extrudes Ca²⁺ from the cell in exchange for Na⁺ entering.
With more intracellular Na⁺, this exchanger’s activity decreases, causing Ca²⁺ retention inside the cell.
3. Increased Sarcoplasmic Ca²⁺
The accumulated intracellular Ca²⁺ is sequestered into the sarcoplasmic reticulum (SR) by SERCA pumps.
Upon subsequent depolarizations, more Ca²⁺ is released from the SR → stronger myocardial contraction.
4. Positive Inotropic Effect
This enhanced Ca²⁺ availability leads to a positive inotropic effect — i.e., increased force of contraction without a significant rise in oxygen consumption.
---
❤️ ๐๐ณ๐ณ๐ฒ๐ฐ๐๐ ๐ผ๐ป ๐๐ต๐ฒ ๐๐ฒ๐ฎ๐ฟ๐
1. Positive Inotropy (↑ Contractility)
Improves cardiac output in heart failure.
Reduces left ventricular end-diastolic volume (LVEDV) and venous pressures.
Enhances renal perfusion, indirectly promoting diuresis.
2. Negative Chronotropy (↓ Heart Rate)
Digoxin increases vagal (parasympathetic) tone, particularly affecting the AV node:
Slows AV nodal conduction.
Prolongs AV nodal refractory period.
Useful in controlling ventricular rate in atrial fibrillation or flutter.
3. Negative Dromotropy (↓ Conduction Velocity)
Due to vagal stimulation and direct depression of AV nodal cells.
Helps prevent rapid ventricular response in supraventricular arrhythmias.
---
๐ง ๐๐๐๐ผ๐ป๐ผ๐บ๐ถ๐ฐ ๐๐ณ๐ณ๐ฒ๐ฐ๐๐
Digoxin influences both branches of the autonomic nervous system:
Enhances vagal tone → slows heart rate and AV conduction.
Reduces sympathetic activity → beneficial in chronic heart failure by lowering catecholamine drive.
---
⚖️ ๐ฃ๐ต๐ฎ๐ฟ๐บ๐ฎ๐ฐ๐ผ๐ฑ๐๐ป๐ฎ๐บ๐ถ๐ฐ ๐ฆ๐๐บ๐บ๐ฎ๐ฟ๐
Effect Mechanism Clinical Outcome
Positive inotropy ↑ intracellular Ca²⁺ via Na⁺/K⁺-ATPase inhibition Improved cardiac output
Negative chronotropy ↑ vagal tone Slower heart rate
Negative dromotropy ↓ AV nodal conduction Controlled ventricular rate in AF
Neurohormonal modulation ↓ Sympathetic, ↑ Parasympathetic Reduced heart failure progression
---
⚠️ ๐๐น๐ถ๐ป๐ถ๐ฐ๐ฎ๐น ๐ฃ๐ฒ๐ฎ๐ฟ๐น๐ ๐ฎ๐ป๐ฑ ๐ง๐ผ๐ ๐ถ๐ฐ๐ถ๐๐
Because of its narrow therapeutic window, digoxin can easily cause toxicity.
Toxic signs:
Bradycardia, AV block
Premature ventricular beats, ventricular tachycardia
GI upset (nausea, vomiting)
Visual disturbances (“yellow vision”)
Predisposing factors:
Hypokalemia, renal impairment, and drug interactions (e.g., amiodarone, verapamil, macrolides).
---
๐ ๐ฆ๐ถ๐บ๐ฝ๐น๐ถ๐ณ๐ถ๐ฒ๐ฑ ๐ฆ๐พ๐๐ฒ๐ฒ๐๐ฒ ๐ ๐ฒ๐ฐ๐ต๐ฎ๐ป๐ถ๐๐บ
Na⁺/K⁺-ATPase ↓ → Na⁺↑ → Ca²⁺↑ → Stronger contraction (↑ Inotropy)
+ Enhanced vagal tone → Slower AV conduction (↓ Rate)
That’s the essence of digoxin’s elegant, century-old yet still-relevant mechanism.
---
๐งฉ ๐๐ฒ๐ ๐ง๐ฎ๐ธ๐ฒ๐ฎ๐๐ฎ๐๐
Primary action: Inhibition of Na⁺/K⁺-ATPase.
Result: Increased intracellular Ca²⁺ → stronger contraction.
Secondary effect: Increased vagal tone → slower heart rate and AV conduction.
Clinical use: Heart failure with reduced ejection fraction, rate control in atrial fibrillation.
Handle with care: Narrow therapeutic index, monitor serum levels and electrolytes.
---
๐ฉบ ๐๐ฎ๐๐ต๐๐ฎ๐ด๐ ๐ณ๐ผ๐ฟ ๐๐น๐ผ๐ด ๐ฆ๐๐ข
#Digoxin #Cardiology #HeartFailure #AtrialFibrillation #NaKATPase #CardiacPharmacology #Inotropy #AVNode #PharmacologyExplained #MedicalEducation

Comments
Post a Comment
Drop your thoughts here, we would love to hear from you